Diabetes drug shows promise against deadly skin cancer in early trial
NCT ID NCT01840007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether metformin, a common diabetes drug, could help treat advanced melanoma that had spread and stopped responding to other treatments. Twenty adults with stage IIIC or IV melanoma took metformin to see if it could shrink their tumors. The goal was to find a new, safer option for a cancer with very few effective treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA (STAGE IIIC NON-RÉSÉCABLE OR NO SURGICALLY CURABLE OR STAGE IV WITH CLASSIFICATION AJCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bahadoran
Nice, Alpes-Maritimes, 06200, France
-
MORTIER Laurent
Lille, Nord, 59000, France